MedPath

Zinc Absorption in Flakes Derived from Sprouted or Hydrothermally Processed Wheat

Not Applicable
Completed
Conditions
Zinc Absorption
Registration Number
NCT06236620
Lead Sponsor
KU Leuven
Brief Summary

The aim of this project is to investigate whether the increased zinc bio-accessibility values in sprouted or hydrothermally processed wheat is reflected in an increased zinc absorption in human subjects after consuming breakfast flakes derived from such processed wheats.

Detailed Description

The zinc study is a randomised crossover design with two different meals (control wheat flakes and flakes derived from sprouted wheat or flakes derived from hydrothermally processed wheat) spiked with a specific zinc isotope. The study contains two test groups (I and II) of 26 and 10 participants, respectively. Both test groups will consume the control wheat flakes, whereas test group I will consume the flakes from sprouted wheat and group II the flakes from hydrothermally processed wheat randomised over two test days. An intravenous dose of Zn will be given on day 1 of the study and the zinc isotope composition in the urine of the participants will be measured on day 1,5,6,7 and 8 of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • BMI range 18.5-25.0 kg/m²
  • Regular diet with 3 meals a day (at least 5 times a week)
Exclusion Criteria
  • Intake of vitamin and/or mineral supplements during and 2 weeks before the stud
  • Intake of antibiotics 3 months prior to the study
  • Intake of medicines that have an impact on the gastrointestinal tract during and 2 weeks before the study
  • Previous or current gastrointestinal (e.g. Crohn's disease), endocrine or eating disorders or other gastrointestinal history
  • Previous or current substance/alcohol dependence or abuse (> 2 units per day/14 units per week)
  • Currently smoking (have smoked in the last 28 days) or willingness to smoke during the study period
  • Pregnant or lactating or wishing to become pregnant in the period of the study
  • Allergy or intolerance to wheat (coeliac disease, gluten sensitivity) or citric acid
  • Adherence to vegan or vegetarian diets or special diets (weight loss, gluten-free etc...)
  • Blood donation in the 6 months prior to the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Zinc absorptionday 1 (before test meal) and day 5,6,7 and 8

Zinc isotope abundance in urine samples

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

KU Leuven/UZ Leuven

🇧🇪

Leuven, Belgium

KU Leuven/UZ Leuven
🇧🇪Leuven, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.